Position in COLL
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$893,849
+$306,719 QoQ
Shares Held
27,029
+113.1% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 20.551999704021608.ToString("F0")%
Shared 0.ToString("F0")%
None 79.44800029597839.ToString("F0")%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $12,857,221 across 26 Drug Manufacturers - Specialty & Generic names. COLL ranks #7 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
21,559 | $2,548,489 | |
| 2 | VTRS |
Viatris Inc
|
184,938 | $2,498,512 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
13,066 | $1,721,314 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,163 | $1,282,615 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
38,245 | $1,151,939 | |
| 6 | HLN |
Haleon plc
|
111,815 | $1,119,268 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
This page
|
27,029 | $893,849 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
38,173 | $792,471 |
All Filings in COLL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $893,849 | 27,029 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $587,130 | 12,681 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $677,966 | 19,376 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $90,099 | 3,047 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $22,477 | 753 | Shares | Sole | 2025-05-15 | |
| 2023-06-30 | $2,922 | 136 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,205 | 217 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $42,641 | 1,838 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||